Targeted plasma multi-omics propose glutathione, glycine and serine as biomarkers for abdominal aortic aneurysm growth on serial CT scanning

• Type: Article in International Scientific Journal
• Date: 2024

Authors

Vanmaele, A (Author) Other; Bouwens, E (Author) Other; Hoeks, SE (Author) Other; Kindt, A (Author) Other; Lamont, L (Author) Other; Fioole, B (Author) Other; Budde, RPJ (Author) Other; ten Raa, S (Author) Other; Hussain, B (Author) Other; Oliveira-Pinto, J (Author) FMUP; Ijpma, AS (Author) Other; van Lier, F (Author) Other; Akkerhuis, KM (Author) Other; Majoor-Krakauer, DF (Author) Other; de Bruin, JL (Author) Other; Hankemeier, T (Author) Other; de Rijke, Y (Author) Other; Verhagen, HJM (Author) Other; Boersma, E (Author) Other; Kardys, I (Author) Other

Journal

Title: Atherosclerosis

Vol. 398

ISSN: 0021-9150

Publisher: Elsevier

Indexing

ISI Web of Knowledge - 0 Citations

Scopus - 0 Citations

Other information

Authenticus ID: P-017-47S

DOI: 10.1016/j.atherosclerosis.2024.118620

Abstract (EN): Background and aims: Abdominal aortic aneurysm (AAA) patients undergo uniform imaging surveillance until reaching the surgical threshold. In spite of the ongoing exploration of AAA pathophysiology, biomarkers for personalized surveillance are lacking. This study aims to identify potential circulating biomarkers for AAA growth on serial CT scans. Methods: Patients with an AAA (maximal diameter >= 40 mm) were included in this multicentre, prospective cohort study. Participants underwent baseline blood sampling and yearly CT-imaging to determine AAA diameter and volume. Proteins and metabolites were measured using proximity extension assay (Olink Cardiovascular III) or separate ELISA panels, and mass-spectrometry (LC-TQMS), respectively. Linear mixed-effects, orthogonal partial least squares, and Cox regression were used to explore biomarker associations with AAA volume growth rate and the risk of surpassing the surgical threshold, as formulated by current guidelines. Results: 271 biomarkers (95 proteins, 176 metabolites) were measured in 109 (90.8 % male) patients with mean age 72. Median baseline maximal AAA diameter was 47.8 mm, volume 109 mL. Mean annual AAA volume growth rate was 11.5 %, 95 % confidence interval (CI) (10.4, 12.7). Median follow-up time was 23.2 months, 49 patients reached the surgical threshold. Patients with one standard deviation (SD) higher glutathione and glycine levels at baseline had an AAA volume growth rate that respectively was 1.97 %, 95%CI (0.97, 2.97) and 1.74 %, 95%CI (0.78, 2.71) larger, relative to the actual aneurysm size. Serine was associated with the risk of reaching the surgical threshold, independent of age and baseline AAA size (cause-specific hazard ratio per SD difference 1.78, 95%CI (1.30, 2.44)). Conclusions: Among multiple intertwined biomarkers related to AAA pathophysiology and progression, glutathione, glycine and serine were most promising.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 8